Type 1 Diabetes Extension Study (T1DES)
- Study HIC#:1512016925
- Last Updated:01/01/0001
To further our understanding of the immunologic mechanisms underlying maintenance and loss of beta cell function by evaluating the relationship between longitudinal changes in beta cell function and changes over time in biomarkers known to be associated with a response to immune modulating treatments which were used in prior clinical trials (Refer to ClinicalTrials.gov records NCT00129259 and NCT00965458).
- Age8 years - 35 years
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Elizabeth Szymanski
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
Multicenter prospective follow-up study of the long term effects of participation in selected completed ITN new-onset TID studies with immunomodulatory agents
Eligibility Criteria
Inclusion Criteria:
- Prior participation in protocol ITN027AI AbATE(NCT00129259) or protocol ITN045AI T1DAL(NCT00965458) studies
- Ability to sign informed consent/assent (as applicable for children)
Exclusion Criteria:
- Any medical condition that in the opinion of the principal investigator would interfere with safe completion of the trial.
- Inability to comply with the study visit schedule and required assessments
